Stockreport

Cartesian Therapeutics Reports Full Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]

Cartesian Therapeutics, Inc.  (RNAC) 
PDF Cartesian Therapeutics, Inc. Enrollment continues to progress in Phase 3 AURORA trial of Descartes-08 in myasthenia gravis Phase 2 TRITON trial of Descartes-08 in d [Read more]